Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doron Lipson

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
European Urology|September 18, 2012
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneityHimisha Beltran, Roman Yelensky, Garrett M Frampton, et al.
The Oncologist|February 28, 2015
Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancerMarina Pekar-Zlotin, Fred R Hirsch, Lior Soussan-Gutman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2013
Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutationsJeffrey S Ross, Kai Wang, Christine E Sheehan, et al.
Cancer Cytopathology|July 30, 2013
Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasmsGeneva Young, Kai Wang, Jie He, et al.
Cancer Research|February 26, 2017
High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer PathogenesisRyan J Hartmaier, Lee A Albacker, Juliann Chmielecki, et al.
Oncoscience|August 6, 2015
Durable clinical benefit to trastuzumab and chemotherapy in a patient with metastatic colon adenocarcinoma harboring ERBB2 amplificationUmut Disel, Alexis Germain, Bahar Yilmazel, et al.
Cancer|December 10, 2015
Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterationsJeffrey S Ross, Kai Wang, Depinder Khaira, et al.
Cancer|June 11, 2016
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapiesJeffrey S Ross, Laurie M Gay, Kai Wang, et al.
Cancer Discovery|August 20, 2015
EGFR Kinase Domain Duplication (EGFR-KDD) Is a Novel Oncogenic Driver in Lung Cancer That Is Clinically Responsive to AfatinibJean-Nicolas Gallant, Jonathan H Sheehan, Timothy M Shaver, et al.
Nature Methods|July 22, 2009
Virtual terminator nucleotides for next-generation DNA sequencingJayson Bowers, Judith Mitchell, Eric Beer, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
European Urology|September 18, 2012
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneityHimisha Beltran, Roman Yelensky, Garrett M Frampton, et al.
The Oncologist|February 28, 2015
Fluorescence in situ hybridization, immunohistochemistry, and next-generation sequencing for detection of EML4-ALK rearrangement in lung cancerMarina Pekar-Zlotin, Fred R Hirsch, Lior Soussan-Gutman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2013
Relapsed classic E-cadherin (CDH1)-mutated invasive lobular breast cancer shows a high frequency of HER2 (ERBB2) gene mutationsJeffrey S Ross, Kai Wang, Christine E Sheehan, et al.
Cancer Cytopathology|July 30, 2013
Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasmsGeneva Young, Kai Wang, Jie He, et al.
Cancer Research|February 26, 2017
High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer PathogenesisRyan J Hartmaier, Lee A Albacker, Juliann Chmielecki, et al.
Oncoscience|August 6, 2015
Durable clinical benefit to trastuzumab and chemotherapy in a patient with metastatic colon adenocarcinoma harboring ERBB2 amplificationUmut Disel, Alexis Germain, Bahar Yilmazel, et al.
Cancer|December 10, 2015
Comprehensive genomic profiling of 295 cases of clinically advanced urothelial carcinoma of the urinary bladder reveals a high frequency of clinically relevant genomic alterationsJeffrey S Ross, Kai Wang, Depinder Khaira, et al.
Cancer|June 11, 2016
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapiesJeffrey S Ross, Laurie M Gay, Kai Wang, et al.
Cancer Discovery|August 20, 2015
EGFR Kinase Domain Duplication (EGFR-KDD) Is a Novel Oncogenic Driver in Lung Cancer That Is Clinically Responsive to AfatinibJean-Nicolas Gallant, Jonathan H Sheehan, Timothy M Shaver, et al.
Nature Methods|July 22, 2009
Virtual terminator nucleotides for next-generation DNA sequencingJayson Bowers, Judith Mitchell, Eric Beer, et al.
Pageof 10